Dantrolene

Safety Summary

Regulatory Status

Sources

No citations are recorded specifically for the human adult context, so the record-wide source list is shown. It backs the record, not this particular band.

• FDA Dantrolene Dantrium Ryanodex Prescribing Information 2022: RyR1 Sarcoplasmic Reticulum Calcium Inhibitor; MH Treatment 2.5 mg/kg IV Mortality Reduced <10%; Oral Hepatotoxicity Warning Fatal Necrosis 0.1%; Spasticity Cerebral Palsy SCI; LFT Monitoring Required REGULATORY · 2022
• PubChem computed properties for CID 6914273 (computed, not measured; as recorded by PubChem) DATABASE · 2026
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• where to look CAMEO Chemicals, as recorded by PubChem (Experimental Properties, CID 6914273; where-to-look, not a source of this value) DATABASE · 2026
• EPA CompTox CTX API: predicted properties for DTXSID7022881 (Dantrolene) REFERENCE
• PubChem computed structure descriptors for CID 6914273 (computed, not measured; as recorded by PubChem) DATABASE · 2026

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.